Citation Impact

Citing Papers

The gut microbiota influences blood-brain barrier permeability in mice
2014 Standout
SNARE Proteins: One to Fuse and Three to Keep the Nascent Fusion Pore Open
2012 StandoutScienceNobel
A fast, single-vesicle fusion assay mimics physiological SNARE requirements
2010 StandoutNobel
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy?
2007
Data mining in the Life Sciences with Random Forest: a walk in the park or lost in the jungle?
2012
Relative Unidirectional Translation in an Artificial Molecular Assembly Fueled by Light
2013 StandoutNobel
Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade
2008 Standout
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
2008
Pancreatic cancer
2004 Standout
SNARE complexes and neuroexocytosis: how many, how close?
2005
Rheumatoid arthritis
2016 Standout
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
Nucleotide signalling during inflammation
2014 StandoutNature
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Central effects of tetanus and botulinum neurotoxins
2009
Structure and function of the blood–brain barrier
2009 Standout
Primary immunodeficiency diseases: An update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee
2007
Hypoxia and Inflammation
2011 Standout
Clinical Pharmacokinetics of Metformin
2011
Ocular Drug Delivery
2010 Standout
Tight junction proteins expression and modulation in immune cells and multiple sclerosis
2011
Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome
2007 Standout
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
The mechanisms of action of metformin
2017 Standout
The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease?
2009
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
2018 Standout
Receptor-targeting mechanisms of pain-causing toxins: How ow?
2012 StandoutNobel
A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis
2011
Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials
2016
MicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole Blood
2010
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
2011 Standout
SNAREs — engines for membrane fusion
2006 Standout
Type 2 diabetes
2017 Standout
Psoriasis genetics: breaking the barrier
2010
Primary immunodeficiencies
2009
The structure and mode of action of different botulinum toxins
2006
The immunology of stroke: from mechanisms to translation
2011 Standout
The theranostic path to personalized nanomedicine
2014
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects
2012
Non-coding RNAs in human disease
2011 Standout
HCV Infection Selectively Impairs Type I but Not Type III IFN Signaling
2013
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
<p>Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics</p>
2019 Standout
Forward genetic analysis of TLR-signaling pathways: An evaluation☆
2008 StandoutNobel
Role of the Blood–Brain Barrier in the Nutrition of the Central Nervous System
2014
Pancreatic Cancer
2010 Standout
CD39 and CD73 in immunity and inflammation
2013 Standout
Metformin and the gastrointestinal tract
2016
The maternal womb
2011
Sex differences in immune responses
2016 Standout
Type 2 diabetes mellitus
2015 Standout
An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis
2011 Standout
Random Forests for Genetic Association Studies
2011
The Y chromosome as a regulatory element shaping immune cell transcriptomes and susceptibility to autoimmune disease
2013
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
2018 StandoutNobel
The SNARE Motif Is Essential for the Formation of Syntaxin Clusters in the Plasma Membrane
2006 StandoutNobel
Pancreatic cancer
2011 Standout
Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells
2004
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections
2014 StandoutNobel
Host Genetics of Mycobacterial Diseases in Mice and Men: Forward Genetic Studies of BCG-osis and Tuberculosis
2007
Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression
2006
Fundamentals of cancer metabolism
2016 Standout
The Therapeutic Potential of Apigenin
2019 Standout
HIF-1–dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia
2005
Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26
2006
Physiological Roles of Vascular Nucleoside Transporters
2007
Rapid Detection of Botulinum Neurotoxins—A Review
2019
Energetically Demanding Transport in a Supramolecular Assembly
2014 StandoutNobel
Biology of Human Sodium Glucose Transporters
2011
The Immune Response in Tuberculosis
2013 Standout
An RNA Profile Identifies Two Subsets of Multiple Sclerosis Patients Differing in Disease Activity
2012
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Random forest in remote sensing: A review of applications and future directions
2016 Standout
Drug transport in corneal epithelium and blood–retina barrier: Emerging role of transporters in ocular pharmacokinetics
2006
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Variable importance analysis: A comprehensive review
2015 Standout
The revival of the Gini importance?
2018 Standout
Physiology of Microglia
2011 Standout
Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism
2004

Works of Joanne Wang being referenced

Taste of a Pill
2014
Botulinum Neurotoxin Serotype a Specific Cell-Based Potency Assay to Replace the Mouse Bioassay
2012
Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells
2006
Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease
2006
Use of MR Cell Tracking to Evaluate Targeting of Glial Precursor Cells to Inflammatory Tissue by Exploiting the Very Late Antigen-4 Docking Receptor
2012
Expression Profiling of the Solute Carrier Gene Family in the Mouse Brain
2009
Selective Transport of Monoamine Neurotransmitters by Human Plasma Membrane Monoamine Transporter and Organic Cation Transporter 3
2010
Pharmacokinetics of Metformin during Pregnancy
2010
Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12 566 individuals
2010
Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter, ENT1
2003
The autoimmune disease–associated IL12B and IL23R polymorphisms in multiple sclerosis
2007
(Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) Mammalian Nucleoside Transporters
2004
Genome-Wide Pharmacogenomic Analysis of the Response to Interferon Beta Therapy in Multiple Sclerosis
2008
Plasma membrane localization signals in the light chain of botulinum neurotoxin
2004
Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event
2008
Identification of the fibroblast growth factor receptor FGFR3 as a component of the receptor complex for Botulinum Neurotoxin Type A
2008
Rankless by CCL
2026